Imipenem plus Fosfomycin as Salvage Therapy for Vertebral Osteomyelitis.
Antimicrob Agents Chemother
; 65(1)2020 12 16.
Article
em En
| MEDLINE
| ID: mdl-32958715
We applied combination antibiotic therapy to treat vertebral osteomyelitis and a psoas abscess caused by glycopeptide-intermediate (MIC, 2 µg/ml) and daptomycin-nonsusceptible (>2 µg/ml) methicillin-resistant Staphylococcus aureus The Etest synergy test showed the largest synergistic effects for imipenem/cilastatin and fosfomycin. Whole-gene sequencing showed amino acid changes in SA0802, SA1193 (mprF), and SA1531 (ald). Four weeks of combination treatment using imipenem/cilastatin (1.5 g per day) and fosfomycin (4.0 g per day) resulted in clinical improvement.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Osteomielite
/
Infecções Estafilocócicas
/
Staphylococcus aureus Resistente à Meticilina
/
Fosfomicina
Limite:
Humans
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article